Trial Profile
Phase I Study of Satraplatin Plus Prednisolone in Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated with a Docetaxel-based Regimen
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Prednisolone (Primary) ; Satraplatin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Yakult Honsha
- 31 May 2016 New trial record